Trials / Withdrawn
WithdrawnNCT01276002
Evaluation of Pancreatic Duct Stenting in Patients With Pancreatic Pseudocysts.
Randomized Multicenter Study on Pancreatic Duct Stenting in Disrupted or Obstructed Ducts in Context With Endoscopic Treatment of Pancreatic Pseudocysts.
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University Hospital Schleswig-Holstein · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The disruption of the pancreatic duct seems to be a major cause pseudocyst formation and persistence in patients suffering from acute/chronic pancreatitis. No prospective randomized studies have been conducted on the influence of pancreatic duct stenting for the patients' benefits and recurrence rates. The aim fo this study is therefore to evaluate prospectively in a randomized, controlled fashion in patients wit pancreatic pseudocysts, wether pancreatic duct stenting of a disrupted pancreatic duct is beneficial in terms of quicker clinical recovery and avoidance of recurrence of pancreatic pseudocysts.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | pancreatic duct stenting | in case of a disrupted pancreatic duct, patients will undergo pancreatic duct stenting. |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2011-01-13
- Last updated
- 2022-07-06
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01276002. Inclusion in this directory is not an endorsement.